RIVER EDGE, N.J., Nov. 21, 2011 /PRNewswire/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that the company has engaged Joseph S. Cervia, M.D. as a strategic consultant.
Joseph S. Cervia, MD, MBA, FACP, FAAP, FIDSA, AAHIVS is Clinical Professor of Medicine and Pediatrics at the Albert Einstein College of Medicine and Hofstra North Shore-LIJ School of Medicine (Division of Infectious Diseases). From 2004 to 2011, he served as Global Medical Director and Senior Vice President for Pall Corporation (NYSE: PLL) where he was responsible for supporting all aspects of the global medical enterprise, including medical and regulatory affairs, research and development, medical marketing and communications, technology assessment, and technical support. A board-certified internist, pediatrician, adult and pediatric infectious diseases and HIV medicine specialist, Dr. Cervia has dedicated much of his career to establishing and leading multi-disciplinary teams in battling infectious diseases, and to education and research in prevention, therapeutics, complicating illnesses, and quality of life issues. He has authored over 100 peer-reviewed articles, chapters, and abstracts; lectures widely; and serves as a consultant to numerous local, national, and international organizations on HIV, infectious diseases, and other health care-related issues. Dr. Cervia earned his B.S. in biology from St. Johns University, his M.D. degree from New York Medical College, and an MBA degree from Regis University. He is a board-certified diplomate in five medical specialties: Internal Medicine, Pediatrics, Adult Infectious Diseases, Pediatric I
|SOURCE Nephros, Inc.|
Copyright©2010 PR Newswire.
All rights reserved